Scopolamine API Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-03-25　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 492.8 Mn
2033 年預估規模: USD 741.7 Mn
年複合成長率 CAGR: 6.2%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-03-25頁數 152報告編號 CMI5270

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Scopolamine API Market, By Form (Powder and Liquid), By Purity (99% and 98%), By Scale of Production (Industrial scale, Pilot scale, and Laboratory scale), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Scopolamine is an alkaloid drug extracted from a plant called henbane to treat nausea and motion sickness and further to dilate the pupil in ophthalmic procedures. Scopolamine belongs to a class of drugs called anticholinergic. Scopolamine is a tropane alkaloid isolated from members of the Solanaceae family of plants, similar to atropine and hyoscyamine, all of which structurally mimic the natural neurotransmitter acetylcholine. It works by blocking the activity of the neurotransmitter acetylcholine, which stimulates the part of the brain that triggers nausea and vomiting, involuntary muscle movement in the lungs, and the gastrointestinal and urinary tracts. Scopolamine is also used in medicine as a sedative or hypnotic and sometimes with morphine to relieve pain. Scopolamine has also been prescribed ‘off label’ for depression, asthma, as a smoking-cessation remedy, and to relieve the nausea that accompanies chemotherapy Market Dynamics Scopolamine is effective in reducing depression and anxiety symptoms due to its anxiety-reducing (anxiolytic) effects. Thus the increasing number of people suffering from anxiety is expected to drive the market growth over the forecast period. For instance, according to the Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S. affecting about 40 million adults aged 18 years and older, or 18.1% of the population every year in the U.S. Moreover, increasing adoption of drug delivery systems such as transdermal patches is expected to drive the market growth over the forecast period. The scopolamine transdermal skin patch is used to prevent nausea and vomiting caused by motion sickness or recovery from anesthesia and surgery. Key features of the study • This report provides in-depth analysis of the global scopolamine API market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global scopolamine API market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Phytex Australia., Aspen Holdings, LGM Pharma, Midas Pharma GmbH, Transo-Pharm Handels-GmbH, Aktin Chemicals,Inc, Merck KgaA, Alchem International Pvt. Ltd., Tiefenbacher API + Ingredients GmbH & Co. KG, Spectrum Chemical, Vital Laboratories Pvt Ltd, Clearsynth, Prism Industries Ltd, Alkaloids Corporation., and Manus Aktteva Biopharma LLP • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global scopolamine API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scopolamine API market Market Segmentation • By Form o Powder o Liquid • By Purity o ≥99% o ≥ 98% • By Scale of Production o Industrial scale o Pilot scale o Laboratory scale • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Phytex Australia. o Aspen Holdings o LGM Pharma o Midas Pharma GmbH o Transo-Pharm Handels-GmbH o Aktin Chemicals,Inc o Merck KgaA o Alchem International Pvt. Ltd. o Tiefenbacher API + Ingredients GmbH & Co. KG o Spectrum Chemical o Vital Laboratories Pvt Ltd o Clearsynth o Prism Industries Ltd o Alkaloids Corporation. o Manus Aktteva Biopharma LLP

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Form  Market Snapshot, By Purity  Market Snapshot, By Scale of Production  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o PEST Analysis o Regulatory Scenario o Epidemiology o Acquisition/Agreement Scenario o Key Highlights/Developments o Challenges in Scopolamine API Market 4. Global Scopolamine API Market, By Form, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Powder  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Liquid  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Scopolamine API Market, By Purity, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o ≥99%  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o ≥ 98%  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Scopolamine API Market, By Scale of Production, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Industrial scale  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Pilot scale  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Laboratory scale  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Scopolamine API Market, By Region, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2022 and 2030 (%)  Y-o-Y Growth Analysis, For Regions, 2021-2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Purity, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Purity, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Purity, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Purity, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Purity, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Form, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Purity, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Mn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Phytex Australia  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Aspen Holdings  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o LGM Pharma  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Midas Pharma GmbH  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Transo-Pharm Handels-GmbH  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Aktin Chemicals,Inc  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Merck KGaA  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Alchem International Pvt. Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Tiefenbacher API + Ingredients GmbH & Co. KG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Spectrum Chemical  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Vital Laboratories Pvt Ltd  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Clearsynth  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Prism Industries Ltd  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Alkaloids Corporation.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Manus Aktteva Biopharma LLP  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us

提及公司

Phytex Australia.Aspen HoldingsLGM PharmaMidas Pharma GmbHTranso-Pharm Handels-GmbHAktin Chemicals,IncMerck KgaAAlchem International Pvt. Ltd.Tiefenbacher API + Ingredients GmbH & Co. KGSpectrum ChemicalVital Laboratories Pvt LtdClearsynthPrism Industries LtdAlkaloids Corporation.Manus Aktteva Biopharma LLP

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們